Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma.

Human pathology - 1 Sept 2018

Lee Hee Eun, Molina Julian R, Sukov William R, Roden Anja C, Yi Eunhee S

Abstract excerpt

Literature on BRCA1-associated protein 1 (BAP1) expression status in well-differentiated papillary mesothelioma (WDPM) is limited. In the present study, we examined the prevalence of BAP1 loss in WDPM by immunohistochemistry with clinical correlation, along with CDKN2A deletion status by fluorescence in situ hybridization (FISH). Eight patients diagnosed as having WDPM were identified from the surgical pathology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Down-Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Mesothelioma

Share to Mesothelioma, Malignant

Share to Neoplasms, Multiple Primary

Share to Neoplasms, Second Primary

Share to Ubiquitin Thiolesterase

Source

Identifiers

PMID: 29763720
DOI: 10.1016/j.humpath.2018.05.001

Genes

BAP1
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma.PMID 29763720Read ↗

Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.Semantic proximity Read ↗

Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant MesotheliomaSemantic proximity Read ↗

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma.Semantic proximity Read ↗

Solid papillary mesothelial tumor.Semantic proximity Read ↗

Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.Semantic proximity Read ↗

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.Semantic proximity Read ↗

Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years.Semantic proximity Read ↗

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.Semantic proximity Read ↗

A Subset of Mesotheliomas With Improved Survival Occurring in Carriers ofBAP1and Other Germline MutationsSemantic proximity Read ↗

High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.Semantic proximity Read ↗

Malignant Mesothelioma in Individuals With Nonmesothelial Neoplasms.Semantic proximity Read ↗

BAP1, a tumor suppressor gene driving malignant mesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.